drugset / Trial / NCT05408546

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

NCT05408546 ↗

Phase 2 Active not recruiting 64 enrolled Translational Sciences, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase II trial of TS23

Timeline

Start
2023-05-24
Primary completion
2026-08-31
Completion
2026-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject TS23 Monoclonal antibody — —

Indications